Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy

Gilead Sciences Current Ratio 2006-2018 | GILD

Current and historical current ratio for Gilead Sciences (GILD) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Gilead Sciences current ratio for the three months ending September 30, 2018 was 3.45.
Gilead Sciences Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $34.92B $10.12B 3.45
2018-06-30 $32.73B $10.91B 3.00
2018-03-31 $30.26B $10.67B 2.84
2017-12-31 $31.82B $11.64B 2.74
2017-09-30 $35.32B $9.60B 3.68
2017-06-30 $28.59B $8.49B 3.37
2017-03-31 $21.42B $8.28B 2.59
2016-12-31 $19.59B $9.22B 2.13
2016-09-30 $21.43B $11.07B 1.94
2016-06-30 $18.35B $10.44B 1.76
2016-03-31 $19.27B $10.91B 1.77
2015-12-31 $24.76B $9.89B 2.50
2015-09-30 $25.91B $9.36B 2.77
2015-06-30 $18.09B $8.93B 2.03
2015-03-31 $20.06B $7.43B 2.70
2014-12-31 $17.71B $5.76B 3.08
2014-09-30 $12.56B $6.06B 2.08
2014-06-30 $15.50B $6.23B 2.49
2014-03-31 $12.97B $5.92B 2.19
2013-12-31 $7.00B $6.41B 1.09
2013-09-30 $6.97B $4.90B 1.42
2013-06-30 $7.07B $4.94B 1.43
2013-03-31 $6.66B $4.29B 1.55
2012-12-31 $6.16B $4.24B 1.45
2012-09-30 $5.88B $4.80B 1.23
2012-06-30 $5.84B $4.99B 1.17
2012-03-31 $5.83B $4.19B 1.39
2011-12-31 $13.92B $2.52B 5.54
2011-09-30 $6.15B $2.22B 2.76
2011-06-30 $6.22B $2.31B 2.69
2011-03-31 $6.85B $2.77B 2.47
2010-12-31 $5.71B $2.47B 2.32
2010-09-30 $6.03B $2.59B 2.33
2010-06-30 $5.71B $3.11B 1.84
2010-03-31 $5.12B $1.89B 2.72
2009-12-31 $4.81B $1.87B 2.57
2009-09-30 $4.30B $1.89B 2.28
2009-06-30 $4.00B $1.78B 2.25
2009-03-31 $4.62B $1.26B 3.66
2008-12-31 $4.28B $1.22B 3.50
2008-09-30 $4.33B $1.26B 3.44
2008-06-30 $3.67B $2.45B 1.50
2008-03-31 $2.95B $0.94B 3.14
2007-12-31 $3.03B $0.74B 4.11
2007-09-30 $2.55B $0.69B 3.68
2007-06-30 $2.45B $0.75B 3.26
2007-03-31 $2.44B $0.71B 3.44
2006-12-31 $2.43B $0.76B 3.18
2006-09-30 $4.03B $0.58B 6.93
2006-06-30 $2.49B $0.51B 4.91
2006-03-31 $3.38B $0.42B 8.00
2005-12-31 $3.09B $0.47B 6.65
2005-09-30 $2.30B $0.27B 8.58
2005-06-30 $2.39B $0.26B 9.13
2005-03-31 $2.07B $0.27B 7.66
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $87.979B $26.107B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $124.200B 14.04
Biogen (BIIB) United States $64.315B 13.02
Celgene (CELG) United States $48.528B 9.42
Illumina (ILMN) United States $44.334B 51.64
Vertex Pharmaceuticals (VRTX) United States $41.163B 71.91
Regeneron Pharmaceuticals (REGN) United States $36.682B 18.58
Alexion Pharmaceuticals (ALXN) United States $25.670B 17.57
BioMarin Pharmaceutical (BMRN) United States $16.686B 0.00
Incyte (INCY) United States $13.673B 377.94
Seattle Genetics (SGEN) United States $9.138B 0.00
Exact Sciences (EXAS) United States $8.269B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.107B 51.83
QIAGEN (QGEN) Netherlands $7.812B 24.99
Sarepta Therapeutics (SRPT) United States $7.776B 0.00
Alnylam Pharmaceuticals (ALNY) United States $7.222B 0.00
BeiGene (BGNE) Cayman Islands $6.685B 0.00
Bluebird Bio (BLUE) United States $6.531B 0.00
Bio-Techne Corp (TECH) United States $5.859B 39.58
Exelixis (EXEL) United States $5.292B 15.00
Alkermes (ALKS) Ireland $5.288B 3403.00
Galapagos (GLPG) Belgium $5.193B 0.00
Amarin (AMRN) Ireland $5.066B 0.00
Horizon Pharma Public (HZNP) Ireland $3.725B 15.32
Emergent Biosolutions (EBS) United States $3.551B 29.91
Immunomedics (IMMU) United States $3.513B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.493B 0.00
Array BioPharma (ARRY) United States $3.243B 0.00
Ligand Pharmaceuticals (LGND) United States $3.157B 24.15
Intercept Pharmaceuticals (ICPT) United States $3.079B 0.00
Allogene Therapeutics (ALLO) United States $3.057B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.813B 0.00
Guardant Health (GH) United States $2.809B 0.00
Repligen (RGEN) United States $2.727B 85.18
Genomic Health (GHDX) United States $2.651B 89.50
Akcea Therapeutics (AKCA) United States $2.646B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.566B 0.00
China Biologic Products (CBPO) China $2.485B 17.69
Ascendis Pharma (ASND) Denmark $2.448B 0.00
Myriad Genetics (MYGN) United States $2.407B 23.84
Acceleron Pharma (XLRN) United States $2.375B 0.00
Allakos (ALLK) United States $2.330B 0.00
Blueprint Medicines (BPMC) United States $2.314B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.266B 0.00
MyoKardia (MYOK) United States $2.266B 0.00
Halozyme Therapeutics (HALO) United States $2.252B 50.26
REGENXBIO (RGNX) United States $2.148B 28.81
Arena Pharmaceuticals (ARNA) United States $2.019B 0.00
Amicus Therapeutics (FOLD) United States $1.948B 0.00
AnaptysBio (ANAB) United States $1.814B 0.00
Reata Pharmaceuticals (RETA) United States $1.800B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.767B 0.00
Denali Therapeutics (DNLI) United States $1.728B 0.00
Global Blood Therapeutics (GBT) United States $1.724B 0.00
Innoviva (INVA) United States $1.665B 9.42
Atara Biotherapeutics (ATRA) United States $1.617B 0.00
Cambrex (CBM) United States $1.597B 11.93
Aimmune Therapeutics (AIMT) United States $1.544B 0.00
Rubius Therapeutics (RUBY) United States $1.533B 0.00
Medicines (MDCO) United States $1.525B 0.00
NeoGenomics (NEO) United States $1.496B 123.69
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.427B 0.00
G1 THERAPEUTICS (GTHX) United States $1.411B 0.00
Spark Therapeutics (ONCE) United States $1.402B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.345B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.321B 0.00
Mirati Therapeutics (MRTX) United States $1.315B 0.00
Insmed (INSM) United States $1.314B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.306B 0.00
Editas Medicine (EDIT) United States $1.298B 0.00
Myovant Sciences (MYOV) United Kingdom $1.272B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.238B 98.33
Solid Biosciences (SLDB) United States $1.183B 0.00
WAVE Life Sciences (WVE) Singapore $1.146B 0.00
IMMURON LTD (IMRN) Australia $1.132B 0.00
Sangamo Therapeutics (SGMO) United States $1.096B 0.00
Lion Biotechnologies (IOVA) United States $1.095B 0.00
UniQure (QURE) Netherlands $1.079B 0.00
Retrophin (RTRX) United States $1.075B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $0.999B 0.00
Momenta Pharmaceuticals (MNTA) United States $0.982B 0.00
Audentes Therapeutics (BOLD) United States $0.970B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.937B 0.00
DBV Technologies (DBVT) France $0.917B 0.00
Acorda Therapeutics (ACOR) United States $0.910B 11.52
Cellectis (CLLS) France $0.904B 0.00
Puma Biotechnology (PBYI) United States $0.880B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.874B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.870B 0.00
Clovis Oncology (CLVS) United States $0.869B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.863B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.846B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.843B 0.00
Intra-Cellular Therapies (ITCI) United States $0.835B 0.00
Viking Therapeutics (VKTX) United States $0.833B 0.00
Apellis Pharmaceuticals (APLS) United States $0.810B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.805B 0.00
Fate Therapeutics (FATE) United States $0.793B 0.00
Coherus BioSciences (CHRS) United States $0.790B 0.00
Athenex (ATNX) United States $0.788B 0.00
Revance Therapeutics (RVNC) United States $0.775B 0.00
Aptinyx (APTX) United States $0.757B 0.00
Heska (HSKA) United States $0.753B 61.60
ProQR Therapeutics (PRQR) Netherlands $0.753B 0.00
Intellia Therapeutics (NTLA) United States $0.725B 0.00
Dynavax Technologies (DVAX) United States $0.723B 0.00
Vericel (VCEL) United States $0.721B 0.00
TWIST BIOSCIENC (TWST) United States $0.709B 0.00
Cara Therapeutics (CARA) United States $0.706B 0.00
Gritstone Oncology (GRTS) United States $0.688B 0.00
AC Immune SA (ACIU) Switzerland $0.671B 0.00
Novavax (NVAX) United States $0.659B 0.00
UROGEN PHARMA (URGN) Israel $0.644B 0.00
ANI Pharmaceuticals (ANIP) United States $0.635B 12.15
AMAG Pharmaceuticals (AMAG) United States $0.629B 0.00
Principia Biopharma (PRNB) United States $0.619B 0.00
InflaRx (IFRX) Germany $0.617B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.611B 0.00
CytomX Therapeutics (CTMX) United States $0.598B 0.00
Epizyme (EPZM) United States $0.594B 0.00
Senesco Technologies (ELOX) United States $0.592B 0.00
AVROBIO (AVRO) United States $0.577B 0.00
Arvinas (ARVN) United States $0.557B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.546B 0.00
RA PHARMCTL INC (RARX) United States $0.542B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.533B 0.00
Scholar Rock Holding (SRRK) United States $0.518B 0.00
Eidos Therapeutics (EIDX) United States $0.517B 0.00
UNITY Biotechnology (UBX) $0.513B 0.00
Arcus Biosciences (RCUS) United States $0.509B 0.00
BeyondSpring (BYSI) United States $0.505B 0.00
Anika Therapeutics (ANIK) United States $0.496B 20.52
Inovio Pharmaceuticals (INO) United States $0.478B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.475B 0.00
Prothena (PRTA) Ireland $0.474B 0.00
Kura Oncology (KURA) United States $0.472B 0.00
Replimune (REPL) United States $0.471B 0.00
Kezar Life Sciences (KZR) United States $0.455B 0.00
Mesoblast (MESO) Australia $0.454B 0.00
ObsEva SA (OBSV) Switzerland $0.451B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.450B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.437B 0.00
Kindred Biosciences (KIN) United States $0.421B 0.00
Sinovac Biotech (SVA) China $0.421B 0.00
PDL BioPharma (PDLI) United States $0.419B 6.83
Sorrento Therapeutics (SRNE) United States $0.407B 66.60
Five Prime Therapeutics (FPRX) United States $0.406B 0.00
Zymeworks (ZYME) Canada $0.403B 0.00
MediciNova (MNOV) United States $0.398B 0.00
Zealand Pharma (ZEAL) Denmark $0.391B 4.32
Achillion Pharmaceuticals (ACHN) United States $0.384B 0.00
Verastem (VSTM) United States $0.383B 0.00
Cytokineticsorporated (CYTK) United States $0.375B 0.00
Osiris Therapeutics (OSIR) United States $0.366B 0.00
Abeona Therapeutics (ABEO) United States $0.364B 0.00
MeiraGTx Holdings (MGTX) United States $0.353B 0.00
Merus (MRUS) Netherlands $0.352B 0.00
ResTORbio (TORC) United States $0.352B 0.00
Stemline Therapeutics (STML) United States $0.337B 0.00
Liquidia Technologies (LQDA) United States $0.334B 0.00
Seres Therapeutics (MCRB) United States $0.327B 0.00
Kodiak Sciences (KOD) United States $0.324B 0.00
LogicBio Therapeutics (LOGC) United States $0.306B 0.00
Cellular Biomedicine (CBMG) United States $0.306B 0.00
Albireo Pharma (ALBO) United States $0.301B 0.00
Krystal Biotech (KRYS) United States $0.298B 0.00
Geron (GERN) United States $0.287B 0.00
Kadmon Holdings (KDMN) United States $0.285B 0.00
Evelo Biosciences (EVLO) United States $0.278B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.276B 0.00
MannKind (MNKD) United States $0.276B 0.00
Athersys (ATHX) United States $0.272B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.271B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.271B 0.00
Sutro Biopharma (STRO) United States $0.264B 0.00
BioDelivery Sciences (BDSI) United States $0.259B 0.00
Equillium (EQ) United States $0.259B 0.00
Celyad SA (CYAD) Belgium $0.254B 0.00
Magenta Therapeutics (MGTA) United States $0.254B 0.00
Agenus (AGEN) United States $0.251B 0.00
Syros Pharmaceuticals (SYRS) United States $0.248B 0.00
Arbutus Biopharma (ABUS) Canada $0.247B 0.00
Aduro Biotech (ADRO) United States $0.240B 0.00
Celcuity (CELC) United States $0.238B 0.00
GAMIDA CELL LTD (GMDA) Israel $0.237B 0.00
Urovant Sciences (UROV) United States $0.237B 0.00
TOCAGEN INC (TOCA) United States $0.236B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.236B 0.00
Strongbridge Biopharma (SBBP) United States $0.235B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.233B 0.00
Adverum Biotechnologies (ADVM) United States $0.233B 0.00
ADMA Biologics Inc (ADMA) United States $0.232B 0.00
Axovant Sciences (AXON) United Kingdom $0.231B 0.00
Unum Therapeutics (UMRX) United States $0.229B 0.00
Synlogic (SYBX) United States $0.223B 0.00
BioTime (BTX) United States $0.222B 0.00
Proteostasis Therapeutics (PTI) United States $0.219B 0.00
Kala Pharmaceuticals (KALA) United States $0.212B 0.00
Kamada (KMDA) Israel $0.211B 19.37
Sienna Biopharmaceuticals (SNNA) United States $0.207B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.204B 0.00
Idera Pharmaceuticals (IDRA) United States $0.197B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.195B 0.00
ChromaDex (CDXC) United States $0.193B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.191B 0.00
Protagonist Therapeutics (PTGX) United States $0.190B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.189B 0.00
Intec Pharma (NTEC) Israel $0.184B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.177B 0.00
Allena Pharmaceuticals (ALNA) United States $0.170B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.169B 0.00
NantKwest (NK) United States $0.166B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.163B 0.00
Compugen (CGEN) Israel $0.159B 0.00
PSivida (EYPT) United States $0.158B 0.00
Menlo Therapeutics (MNLO) United States $0.153B 0.00
XBiotech (XBIT) United States $0.150B 0.00
Constellation Pharmaceuticals (CNST) United States $0.149B 0.00
Enzo Biochem (ENZ) United States $0.149B 0.00
Cerecor (CERC) United States $0.146B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.145B 0.00
Pfenex (PFNX) United States $0.142B 0.00
Spero Therapeutics (SPRO) United States $0.142B 0.00
Palatin Technologies (PTN) United States $0.138B 17.00
Eleven Biotherapeutics (SESN) United States $0.135B 0.00
Mersana Therapeutics (MRSN) United States $0.132B 0.00
Cohbar (CWBR) United States $0.130B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.128B 0.00
Selecta Biosciences (SELB) United States $0.127B 0.00
CorMedix Inc (CRMD) United States $0.126B 0.00
Pluristem Therapeutics (PSTI) Israel $0.126B 0.00
Catalyst Biosciences (CBIO) United States $0.126B 0.00
Applied Genetic Technologies (AGTC) United States $0.125B 0.00
Mustang Bio (MBIO) United States $0.118B 0.00
XOMA (XOMA) United States $0.118B 0.00
VBI Vaccines (VBIV) United States $0.117B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.116B 0.00
Organovo Holdings (ONVO) United States $0.115B 0.00
Motif Bio Plc (MTFB) United States $0.114B 0.00
Anavex Life Sciences (AVXL) United States $0.105B 0.00
OVID THERAPEUTC (OVID) United States $0.103B 0.00
Signal Genetics (MGEN) United States $0.102B 0.00
Cidara Therapeutics (CDTX) United States $0.102B 0.00
Cue Biopharma (CUE) United States $0.102B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.101B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.098B 0.00
Provention Bio (PRVB) United States $0.098B 0.00
Chiasma (CHMA) United States $0.093B 0.00
Neothetics (EVFM) United States $0.093B 0.00
Axsome Therapeutics (AXSM) United States $0.092B 0.00
Cocrystal Pharma (COCP) United States $0.089B 98.72
BioXcel Therapeutics (BTAI) United States $0.088B 0.00
Orgenesis (ORGS) United States $0.086B 0.00
VolitionRX (VNRX) Singapore $0.083B 0.00
Aptose Biosciences (APTO) Canada $0.083B 0.00
Cel-Sci (CVM) United States $0.080B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.080B 0.00
Checkpoint Therapeutics (CKPT) United States $0.079B 0.00
Ophthotech (OPHT) United States $0.078B 0.00
ScPharmaceuticals (SCPH) United States $0.077B 0.00
VTv Therapeutics (VTVT) United States $0.075B 0.00
Fortress Biotech (FBIO) United States $0.074B 0.00
Alimera Sciences (ALIM) United States $0.074B 0.00
ITUS (ANIX) United States $0.072B 0.00
Prima BioMed (IMMP) Australia $0.071B 0.00
Vaccinex (VCNX) United States $0.071B 0.00
Bionano Genomics (BNGO) United States $0.070B 0.00
Alcobra (ARCT) United States $0.070B 0.00
NewLink Genetics (NLNK) United States $0.070B 0.00
PHASEBIO PHARMA (PHAS) United States $0.069B 0.00
Asterias Biotherapeutics (AST) United States $0.067B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.066B 0.00
Monster Digital (INNT) United States $0.065B 0.00
Versartis (ARAV) United States $0.063B 5.55
Protalix BioTherapeutics (PLX) Israel $0.062B 0.00
Evogene (EVGN) Israel $0.062B 0.00
Entera Bio (ENTX) Israel $0.061B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.060B 0.00
Aptevo Therapeutics (APVO) United States $0.060B 0.00
Sophiris Bio (SPHS) United States $0.059B 0.00
Clearside Biomedical (CLSD) United States $0.056B 0.00
Bellerophon Therapeutics (BLPH) United States $0.056B 0.00
Leap Therapeutics (LPTX) United States $0.055B 0.00
Celldex Therapeutics (CLDX) United States $0.055B 0.00
VistaGen Therapeutics (VTGN) United States $0.055B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.054B 8.71
Oncobiologics (ONS) United States $0.053B 0.00
Trevena (TRVN) United States $0.050B 0.00
AEterna Zentaris (AEZS) United States $0.049B 9.38
OncoSec Medical (ONCS) United States $0.048B 0.00
Curis (CRIS) United States $0.048B 0.00
Zosano Pharma (ZSAN) United States $0.046B 0.00
Caladrius Biosciences (CLBS) United States $0.044B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.043B 0.00
Oncolytics Biotech (ONCY) Canada $0.043B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.042B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.041B 0.00
Vascular Biogenics (VBLT) Israel $0.040B 0.00
Moleculin Biotech (MBRX) United States $0.038B 0.00
AquaBounty Technologies (AQB) United States $0.037B 0.00
AZURRX BIOPHARM (AZRX) United States $0.037B 0.00
TRACON Pharmaceuticals (TCON) United States $0.036B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.036B 0.00
Celsion (CLSN) United States $0.035B 0.00
GTx (GTXI) United States $0.034B 0.00
Galena Biopharma (SLS) United States $0.033B 0.00
Aileron Therapeutics (ALRN) United States $0.032B 0.00
VIVUS (VVUS) United States $0.032B 0.00
BioPharmX (BPMX) United States $0.032B 0.00
Proteon Therapeutics (PRTO) United States $0.032B 0.00
Eyenovia (EYEN) United States $0.031B 0.00
Therapix Biosciences (TRPX) Israel $0.028B 10.51
Histogenics (HSGX) United States $0.028B 0.00
Vical (VICL) United States $0.027B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.026B 0.00
Benitec Biopharma (BNTC) Australia $0.026B 0.00
Advaxis (ADXS) United States $0.025B 0.00
OvaScience (OVAS) United States $0.025B 0.00
Cellect Biotechnology (APOP) Israel $0.021B 0.00
Edge Therapeutics (EDGE) United States $0.021B 0.00
Cleveland BioLabs (CBLI) United States $0.020B 0.00
CytRx (CYTR) United States $0.020B 0.00
GENPREX INC (GNPX) United States $0.020B 0.00
Pulmatrix (PULM) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
Novelion Therapeutics (NVLN) Canada $0.018B 0.00
TrovaGene (TROV) United States $0.018B 0.00
Arsanis (ASNS) United States $0.018B 0.00
ATyr Pharma (LIFE) United States $0.017B 0.00
Soligenix (SNGX) United States $0.017B 0.00
Gemphire Therapeutics (GEMP) United States $0.016B 0.00
Prana Biotechnology (PRAN) Australia $0.015B 0.00
IBio (IBIO) United States $0.015B 0.00
RestorGenex (DFFN) United States $0.015B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
Vital Therapies (VTL) United States $0.012B 0.00
Novogen (KZIA) Australia $0.012B 0.00
Synthetic Biologics (SYN) United States $0.011B 0.00
Oragenics (OGEN) United States $0.010B 0.00
Cerulean Pharma (DARE) United States $0.010B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
Neuralstem (CUR) United States $0.009B 0.00
Adial Pharmaceuticals (ADIL) United States $0.009B 0.00
Alliqua BioMedical (ALQA) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
AmpliPhi Biosciences (APHB) United States $0.008B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Titan Pharmaceuticals (TTNP) United States $0.008B 0.00
Aytu Bioscience (AYTU) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00